Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wollstonecraft
Clinical trial register · Australia

Clinical Trials in Wollstonecraft, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Melanoma Institute Australia9 Immunocore Ltd4 Strand Therapeutics Inc.2 Bristol-Myers Squibb2 Pierre Fabre Medicament2
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Wollstonecraft

31 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Strand Therapeutics Inc.
Phase 1/2
220
Wollstonecraft
2026-06-30
Recruiting
Melanoma Institute Australia
Phase 2
494
Wollstonecraft
2026-02-09
Recruiting
The Multicentre Selective Lymphadenectomy Trial - 3
NCT07049276Cutaneous Melanoma, Stage III
Melanoma Institute Australia
Not applicable
1,500
Newcastle, Wollstonecraft, Murdoch
2025-10-01
Recruiting
BioNTech SE
Phase 1/2
1,438
Blacktown, Darlinghurst, Wollstonecraft, Southport, Adelaide, Frankston, Heidelberg, Melbourne
2025-08-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Blacktown, Wollstonecraft, Nedlands
2025-05-29
Recruiting
Melanoma Institute Australia
Phase 2
129
Westmead, Wollstonecraft, Woolloongabba, Melbourne
2025-03-06
Recruiting
Replimune, Inc.
Phase 2/3
280
Wollstonecraft, Melbourne
2024-12-17
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Adelaide, Nedlands, Wollstonecraft
2024-11-07
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Lismore, Westmead, Wollstonecraft, Douglas, Hervey Bay, Bedford Park, Woodville, Hobart
2024-09-18
Recruiting
Melanoma Institute Australia
Phase 2
20
Wollstonecraft
2024-06-21
Recruiting
Immunocore Ltd
Phase 3
680
Waratah, Greenslopes, Nedlands, Heidelberg, North Melbourne, Wollstonecraft, Woolloongabba
2024-06-05
Recruiting
Strand Therapeutics Inc.
Phase 1/2
108
Wollstonecraft
2024-05-03
Recruiting
Melanoma Institute Australia
Phase 2
20
Wollstonecraft
2024-03-11
Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
NCT06060613Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer
Obsidian Therapeutics, Inc.
Phase 1/2
254
Wollstonecraft
2023-10-25
Active, closed
Melanoma Institute Australia
Phase 2
20
Wollstonecraft
2023-08-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Westmead, Wollstonecraft, Brisbane, Melbourne, Nedlands
2023-07-19
Active, closed
Bristol-Myers Squibb
Phase 3
579
Coffs Harbour, Orange, Port Macquarie, Wagga Wagga, Waratah, Westmead, Wollstonecraft, Birtinya
2023-03-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Blacktown, Lismore, Liverpool, Wollstonecraft, Bedford Park, North Adelaide, Box Hill, Geelong
2023-01-16
Recruiting
Immunocore Ltd
Phase 3
540
Wollstonecraft, Greenslopes, Woolloongabba, Melbourne
2022-12-19
Active, closed
Evaxion Biotech A/S
Phase 2
17
Wollstonecraft, Nedlands
2022-09-19
Recruiting
ModernaTX, Inc.
Phase 1/2
361
Miranda, Wollongong, Wollstonecraft, Melbourne, Nedlands
2022-09-01
Active, closed
Pierre Fabre Medicament
Phase 3
815
Sydney, Wollstonecraft, Woolloongabba, North Adelaide, Box Hill, Heidelberg, Prahran, Nedlands
2022-05-02
Active, closed
Pfizer
Phase 3
77
North Ryde, Wollstonecraft, Chermside
2021-09-29
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Albury, Campbelltown, Liverpool, Northmead, Port Macquarie, Wollstonecraft, Auchenflower, Brisbane
2021-08-27
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Waratah, Wollstonecraft, Southport, Heidelberg, Perth
2021-08-04
Active, closed
Melanoma and Skin Cancer Trials Limited
Not applicable
670
Camperdown, Newcastle, Sydney, Wollstonecraft, Brisbane, Cairns, Townsville, Bendigo
2021-03-03
Active, closed
Immunocore Ltd
Phase 1/2
410
Randwick, Wollstonecraft, Melbourne, Nedlands
2020-02-25
Active, closed
Bristol-Myers Squibb
Phase 3
790
Waratah, Westmead, Wollstonecraft, Cairns, Greenslopes, Herston, Southport, Box Hill
2019-10-28
Recruiting
Melanoma Institute Australia
Phase 2
218
Sydney, Waratah, Wollstonecraft, Woolloongabba, Adelaide, East Melbourne, Melbourne, Perth
2019-08-14
Active, closed
Melanoma Institute Australia
Phase 2
60
Sydney, Wollstonecraft, Melbourne
2017-11-08
Active, closed
Melanoma Institute Australia
Phase 2
76
Wollstonecraft, Woolloongabba, Adelaide, East Melbourne
2014-11-04
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/wollstonecraft

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies with a site in Wollstonecraft.

How many clinical trials are recruiting in Wollstonecraft?

17 of the 31 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wollstonecraft), 31 studies
PhaseStudiesRecruitingShare
Phase 211635.5%
Phase 39229%
Phase 1/26519.4%
Not applicable216.5%
Phase 1226.5%
Phase 2/3113.2%

Most active sponsors

Lead sponsors with the most studies (Wollstonecraft)
Lead sponsorStudiesRecruiting
Melanoma Institute Australia96
Immunocore Ltd43
Bristol-Myers Squibb20
Merck Sharp & Dohme LLC21
Pierre Fabre Medicament21
Regeneron Pharmaceuticals20
Strand Therapeutics Inc.22
BioNTech SE11
Evaxion Biotech A/S10
Hoffmann-La Roche10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.